Bioprocess Technology Market Size, Share, Growth, Trends | Report 2022-2030
The global bioprocess technology market was estimated at USD 35.28 billion in 2022 and it is expected to surpass around USD 100.82 billion by 2032, poised to grow at a CAGR of 11.07% from 2023 to 2032.
Key Pointers
Report Scope of the Bioprocess Technology Market
| Report Coverage | Details |
| Market Size in 2022 | USD 35.28 billion |
| Revenue Forecast by 2032 | USD 100.82 billion |
| Growth rate from 2023 to 2032 | CAGR of 11.07% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Thermo Fisher Scientific Inc., Lonza Group, Merck KGaA, GE Healthcare Company, Danaher Corporation, Sartorius AG, Corning Incorporated, Bio-rad Laboratories Inc, and LCG Group. |
Bioprocess technology refers to the industrial use of biological processes utilizing living cells or their component units to achieve desired substrate transformation. The main benefits of using bioprocesses over conventional chemical ones are that they produce renewable by-products, need mild reaction conditions, and are more focused and efficient (biomass). The potential of bioprocesses has increased, and it has been broadened with the emergence of recombinant DNA technology. A key component of biotechnology is bioprocess technology, which deals with procedures that combine the entire living organism or its component units with nutrients to create specialized compounds, reagents, and biotherapeutics. The methods are the foundation for converting discoveries in the life sciences into practical industrial products. Substrates and media, biocatalysts, volume production, downstream processing, purification, and final processing are a few of the several processes connected to bioprocess technology. The development of numerous next-generation biopharmaceutical products using bioprocess technology has gained traction in the bioprocess technology industry during the past few years.
Bioprocess technology is referred to as the industrial application of biological processes, including living cells or their components, to yield the expected transformation of substrates. The processes form the backbone of translating life sciences discoveries into useful industrial products. The significant advantages of bioprocesses over traditional chemical processes are that they require mild reaction conditions, are more precise and efficient, and produce renewable by-products (biomass). The development of recombinant DNA technology has grown and expanded the potential of bioprocesses.
The growth of this market is mainly attributed to the raised funding for research and development of bioprocessing technology, an increase in the production of vaccines, and constant technological advancements in bioprocess. Moreover, improving support from the government of different countries in biofuel production is further predicted to push the growth of the bioprocess technology market.
In addition, Bioprocess technology is likely to experience considerable demand from the pharmaceutical sector, owing to the increasing incidences of infectious and chronic diseases like cancer. Biopharmaceutical outsourcing is emerging as a profitable strategy to address the unmet medical needs among patients. It has led to a rise in bioprocessing systems with better process efficiency and throughput. These systems offer an advantage for adherence to regulatory compliance processes. Many biopharmaceutical companies are opting for single-use systems, as they deliver cost-efficiency and technological advancements due to growing capacities and capabilities. However, strict supervisory policies and the high technology cost restrain the bioprocess technologies market growth.
Bioprocess Technology Market Segmentations:
| By Product Type | By Application | By End-Use |
|
Biologics Safety Testing Cell Culture Cell Expansion Cell Line Development Flow Cytometry Tangential Flow Filtration Flow Cytometry |
Antibiotics Biosimilars Recombinant Proteins Others |
Biopharmaceutical Companies Contract Manufacturing Organization Academic Research Institutes Food and Feed Industry Contract Research Organization |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioprocess Technology Market
5.1. COVID-19 Landscape: Bioprocess Technology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioprocess Technology Market, By Product Type
8.1. Bioprocess Technology Market, by Product Type, 2023-2032
8.1.1 Biologics Safety Testing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Cell Culture
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Cell Expansion
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cell Line Development
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Flow Cytometry
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Tangential Flow Filtration
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Flow Cytometry
8.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Bioprocess Technology Market, By Application
9.1. Bioprocess Technology Market, by Application, 2023-2032
9.1.1. Antibiotics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Biosimilars
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Recombinant Proteins
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Bioprocess Technology Market, By End-Use
10.1. Bioprocess Technology Market, by End-Use, 2023-2032
10.1.1. Biopharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Contract Manufacturing Organization
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Academic Research Institutes
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Food and Feed Industry
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Contract Research Organization
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Bioprocess Technology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Lonza Group, Merck KGaA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. GE Healthcare Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Danaher Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sartorius AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Corning Incorporated
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-rad Laboratories Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. LCG Group.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers